Stay updated on Ruxolitinib for Eosinophilic Disorders Clinical Trial

Sign up to get notified when there's something new on the Ruxolitinib for Eosinophilic Disorders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ruxolitinib for Eosinophilic Disorders Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the prior v3.4.1 notice removed, indicating an administrative update. No core content or study details were changed; to avoid alerts for minor updates, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:19:53.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide government funding/status notice was added and the page shows Revision: v3.4.1, replacing the previous v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T00:55:39.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page adds a glossary and new QC-related fields (Last Update Submitted that Met QC Criteria, Last Update Posted, Revision: v3.4.0) while removing older QC indicators and No FEAR Act data entries (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4).
    Difference
    0.3%
    Check dated 2026-01-28T00:03:12.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 in the page header. The study details page content and layout remain unchanged.
    Difference
    0.1%
    Check dated 2026-01-13T17:45:28.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Added Principal Investigator and Last Update Posted (Estimated) fields; updated the study title display. Removed the old Contact field and the prior Last Update Posted information.
    Difference
    0.5%
    Check dated 2025-12-30T09:09:38.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    A new 'Locations' section was added listing California, Oregon, Utah, and Washington sites, and the previous state-specific location entries were removed; revision updated from v3.3.2 to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-23T08:50:05.000Z thumbnail image

Stay in the know with updates to Ruxolitinib for Eosinophilic Disorders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ruxolitinib for Eosinophilic Disorders Clinical Trial page.